Local Institution - 501

Seoul 06351

0 studies enrolling now · 1 studies all time

What they study most

Lymphoma

Studies at this site

• A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas — Stopped early